Los Angeles Capital Management Portfolio holdings
AUM
$26.7B
1-Year Return
35.08%
This Quarter Return
+16.76%
1 Year Return
+35.08%
3 Year Return
+164.18%
5 Year Return
+293.76%
10 Year Return
+832%
AUM
$29.3B
AUM Growth
+$2.52B
(+9.4%)
Cap. Flow
-$621M
Cap. Flow
% of AUM
-2.12%
Top 10 Holdings %
Top 10 Hldgs %
34.45%
Holding
1,250
New
131
Increased
366
Reduced
518
Closed
126
Top Buys
| 1 |
NetApp
NTAP
|
+$174M |
| 2 |
Amazon
AMZN
|
+$159M |
| 3 |
Netflix
NFLX
|
+$134M |
| 4 |
Citigroup
C
|
+$121M |
| 5 |
Eaton
ETN
|
+$99.5M |
Top Sells
| 1 |
Amgen
AMGN
|
+$260M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$150M |
| 3 |
Tesla
TSLA
|
+$141M |
| 4 |
Visa
V
|
+$114M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$107M |
Sector Composition
| 1 | Technology | 33.23% |
| 2 | Consumer Discretionary | 14.97% |
| 3 | Financials | 13.46% |
| 4 | Industrials | 11.6% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Protagonist Therapeutics
PTGX
$3.67B
| $892K | ﹤0.01% |
30,827
+21,673
| +237% | +$627K |
|
727
Sapiens International
SPNS
$2.4B
| $887K | ﹤0.01% |
27,580
| – | – |
|
728
Mersana Therapeutics
MRSN
$36M
| $883K | ﹤0.01% |
7,887
-12
| -0.2% | -$1.34K |
|
729
Roku
ROKU
$13.7B
| $883K | ﹤0.01% |
13,547
-52,782
| -80% | -$3.44M |
|
730
Centrus Energy
LEU
$4.05B
| $880K | ﹤0.01% |
21,183
+33
| +0.2% | +$1.37K |
|
731
JFrog
FROG
$5.87B
| $879K | ﹤0.01% |
19,885
+122
| +0.6% | +$5.4K |
|
732
American Woodmark
AMWD
$997M
| $878K | ﹤0.01% |
8,639
-147
| -2% | -$14.9K |
|
733
Essent Group
ESNT
$6.34B
| $870K | ﹤0.01% |
14,625
-1,432
| -9% | -$85.2K |
|
734
Sierra Bancorp
BSRR
$413M
| $870K | ﹤0.01% |
43,080
-540
| -1% | -$10.9K |
|
735
FirstEnergy
FE
$25.2B
| $866K | ﹤0.01% |
+22,435
| New | +$866K |
|
736
Helmerich & Payne
HP
$2.1B
| $865K | ﹤0.01% |
20,566
-113
| -0.5% | -$4.75K |
|
737
LiveRamp
RAMP
$1.73B
| $852K | ﹤0.01% |
24,710
+115
| +0.5% | +$3.97K |
|
738
ACM Research
ACMR
$1.94B
| $852K | ﹤0.01% |
+29,242
| New | +$852K |
|
739
Danaher
DHR
$137B
| $850K | ﹤0.01% |
3,405
-65
| -2% | -$16.2K |
|
740
Great Southern Bancorp
GSBC
$712M
| $847K | ﹤0.01% |
15,455
| – | – |
|
741
Harmony Biosciences
HRMY
$1.87B
| $847K | ﹤0.01% |
25,224
+1,076
| +4% | +$36.1K |
|
742
Genworth Financial
GNW
$3.61B
| $846K | ﹤0.01% |
131,621
+4,435
| +3% | +$28.5K |
|
743
Inspired Entertainment
INSE
$253M
| $846K | ﹤0.01% |
85,784
-67,373
| -44% | -$664K |
|
744
AtriCure
ATRC
$1.8B
| $842K | ﹤0.01% |
+27,693
| New | +$842K |
|
745
Univest Financial
UVSP
$887M
| $842K | ﹤0.01% |
40,445
-310
| -0.8% | -$6.45K |
|
746
Stoke Therapeutics
STOK
$1.25B
| $840K | ﹤0.01% |
62,257
| – | – |
|
747
Biglari Holdings Class B
BH
$965M
| $840K | ﹤0.01% |
4,430
-1,136
| -20% | -$215K |
|
748
Best Buy
BBY
$16.1B
| $828K | ﹤0.01% |
10,095
+4,550
| +82% | +$373K |
|
749
Regency Centers
REG
$13B
| $825K | ﹤0.01% |
13,626
-46,127
| -77% | -$2.79M |
|
750
Griffon
GFF
$3.65B
| $822K | ﹤0.01% |
11,206
-1,626
| -13% | -$119K |
|